Bausch & Lomb Stellaris PC
This article was originally published in The Gray Sheet
Executive Summary
Firm announces Aug. 19 510(k) clearance of its Stellaris PC (Procedural Choice) vision enhancement system for cataract, retina and combined cataract/retina surgery. The product is a combined vitrectomy and phacoemulsification system. Stellaris was originally cleared in 2007 for cataract surgery only; the new multi-procedure system gained CE mark approval in May (1"The Gray Sheet" Aug. 23, 2010)
You may also be interested in...
New Products In Brief
Bausch & Lomb's Stellaris PC: Company debuts its Stellaris PC (Procedural Choice) vision enhancement system overseas following CE mark approval last May. The combined vitrectomy and phacoemulsification system, for which a May 510(k) submission remains pending at FDA, enhances surgeons' ability to see ocular tissue under various surgical conditions, B&L claims. Stellaris PC is indicated for emulsification and removal of cataracts, and anterior and posterior segment vitrectomy
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.